Unveiling the Potential of Digital Intelligence to Empower Pharmaceutical Companies
In this GEN webinar, Storyful CEO Maria Pacheco will showcase several real-time examples that illustrate how access to digital intelligence can be timely, impactful, and agile for marketing communications strategy or PR in the pharmaceutical industry.
Strategies for Determining Critical Quality Attributes of Nucleic Acid Therapeutics and Their Carriers
In this GEN webinar, our expert speaker Oliver Höcker, PhD, will discuss the advantages and limitations of current analytical techniques for determining the CQAs of NA therapeutics using examples from different NA classes.
Using Multiplexed Multi-Omics to Study Spatial Heterogeneity in Ovarian Cancer
In this GEN webinar,
Endpoints: Critical Preclinical Markers in Neurodegeneration Disease Assays
In this GEN webinar, our speaker John Renger, PhD, CSO at Cerevel Therapeutics, discusses preclinical markers used in assays relevant to neurodegenerative disease processes, including the evaluation of autophagy and mitophagy using methods such as immunohistochemistry, western blotting, ELISA-like assays, high content analysis, and other platforms.
Biologics Drug Development Gets an Upgrade with Humanized Animal Models
In this GEN webinar, Aaron Rose, PhD, explores how biological therapeutics are reshaping the traditional drug development process and why humanized models are essential for advancing biologics programs.
Customized mRNA Processing for Improved Therapy Development and Manufacturing
In this GEN webinar, Scott Alderucci will discuss ways of leveraging new technologies and experimental design for an optimized, tailored approach to mRNA therapy development.
Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data
In this GEN webinar, two experts, Prashant Vaidyanathan, PhD, and Rob Brown, PhD, will discuss advancements in configurable lab workflows, AI ChatGPT, and next-generation lab informatics that are enabling novel discoveries in cell and gene therapy.
Detecting Growing Tumors through Changes in the Plasma Proteome
On this GEN webinar, SomaLogic CSO Nebojsa Janjic, PhD, will discuss the need for a reliable blood-based screening method capable of detecting cancers earlier.
dPCR vs. qPCR: Selecting the Right Tool for Molecular Analysis
In this GEN webinar, our panelists Jim Huggett, PhD, and Boshen Gao will introduce the dPCR workflow and discuss this technology’s advantages over traditional qPCR including higher precision, more flexibility, increased sensitivity, and true absolute quantification.
Using AI-Based Spatial Analysis to Explore Immunotherapy Biomarkers
In this GEN webinar, our speakers Ettai Markovits, MD, and Arutha Kulasinghe, PhD, will discuss how AI-based spatial analysis of mIF data can accelerate the discovery of clinically relevant biomarkers that can predict response and resistance mechanisms to immunotherapy.
Simplifying Scale-up Manufacturing of RNA-LNPs for Vaccine and Cell Therapy Applications
In this GEN webinar, our expert speaker, Ian Johnston from Cytiva, discusses a genomic medicine toolkit for developing RNA-LNP medicines.
Vaccine Development: Multiplexed Solutions on the InDevR VaxArray Platform
In this webinar, Dr. Kopcho from InDevr will demonstrate the flexibility of the VaxArray platform through a variety of case studies and customer examples that include the utility of InDevR’s off-the-shelf kits for influenza vaccines and pneumococcal conjugate vaccines, as well as a variety of custom kits.
Organoids from Amniotic Fluid Cells: A Landmark Achievement That Will Broaden Research
In this GEN keynote webinar, Mattia Gerli, PhD, and Paolo De Coppi, MD, (University College London, Institute of Child Health) will reveal how their team achieved this landmark in organoid research.
Uncovering RNA Splicing’s Cell-Specific Impact on Clonal Blood Disorders with GoT-Splice
In this GEN webinar, Dr. Mariela Cortés López will present a novel approach, GoT-Splice, developed by the Landau lab at the New York Genome Center in collaboration with the Abdel-Wahab lab at MSKCC that integrates genotyping of transcriptomes (GoT) with Oxford Nanopore long-read single-cell transcriptome profiling and proteogenomics.
How AI-Supported Spatial Analysis and Multiplex Assays Elucidate the Tumor Microenvironment
In this GEN webinar, Michael Downing, Senior Image Analysis Scientist at Ultivue, will review the state of the field and introduce Ultivue’s two core platform technologies.
QSP Modeling: How Biosimulation Can Bolster Cell and Gene Therapy Development
In this GEN webinar, our expert speakers will discuss how QSP modeling improves early feasibility assessment, rational therapy design, and clinical development of cell and gene therapies.